Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma
Clinical trial NCT01597908 · COMPLETED
Trial details
- NCT number
- NCT01597908
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-04
- Primary completion
- 2014-04-17
- Enrollment
- 704
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.